
Sign up to save your podcasts
Or


We asked Dr. Mohamed Genead, Chief Medical Officer, Nanoscope Therapeutics to discuss and review the latest developments in optogenetic gene therapy for retinal degenerations.
By Retina Synthesis4.5
88 ratings
We asked Dr. Mohamed Genead, Chief Medical Officer, Nanoscope Therapeutics to discuss and review the latest developments in optogenetic gene therapy for retinal degenerations.

18 Listeners

2,445 Listeners

112,802 Listeners

674 Listeners

56,532 Listeners

596 Listeners

4 Listeners

11 Listeners

51 Listeners

10 Listeners

18 Listeners

2 Listeners

0 Listeners

840 Listeners